Michael Barbella, Managing Editor03.21.22
NanoVibronix Inc . has welcomed two new members to its Board of Direcctors.
The company recently appointed Aurora (Rori) Cassirer and Maria (Lulu) Schroeder to serve as independent directors. Cassirer will serve on the compensation and nominating and governance committees and Schroeder will serve on the Audit Committee. The board is now comprised of eight directors, six of whom are considered ‘independent’ as defined under Nasdaq Listing Rules.
Cassirer is a highly experienced attorney, who has served as a partner in prominent law firms for more than 30 years including Troutman Pepper, where she served on the Executive and Compensation committees, and Jenkins & Gilchrist. In addition to her management responsibilities, Rori has a practice focusing on business litigation and corporate governance issues. She has developed a particular niche in dealing with publicly and privately held biotech/healthtech and biopharma companies. Cassirer has been listed as AV Preeminent by Martindale-Hubbell consistently for the last 20 years as well as being listed in Law & Politics’ New York Super Lawyers for excellence in Business Litigation every year since 2008. Previously, she chaired the Advisory Board of ReferWell, formerly known as Urgent Consult LLC, a health technology startup. She also serves on the Board of Directors of Kids in Need of Defense (KIND), a not-for-profit organization where she served on its Compensation Committee. She is also a member of the Board of Friends of Jerusalem College of Technology and serves on its Development Committee. Cassirer serves as co-chair of the New York State Bar Association International Corporate Compliance Committee and on the Advisory Board of LiveCare Corp., a company that manufactures and distributes remote patient monitoring devices. Cassirer earned her J.D. from New York University.
Schroeder has been a key financial executive at various public and privately-held companies including CST Brands, KCI and Brain Sentinel, where she recently served as chief financial officer. Prior to Brain Sentinel, Schroeder served as vice president, Global Tax of CST Brands, a Fortune 250 retail Oil and Gas company. Prior to that, she served as vice president and treasurer, and head of Tax at Kinetic Concepts Inc. (KCI), a $1.5 billion medtech company that was recently purchased by 3M for $6.7 billion. At KCI, she held key roles in a number of strategic transactions, including two leveraged buyouts and an initial public offering. Schroeder began her career at Ernst & Whinney before joining Deloitte Haskins & Sells. Schroeder is an alumnus of San Antonio Leadership, a premier leadership program of the San Antonio Chamber of Commerce and has served on the Audit Committee for The University of Texas at San Antonio, as treasurer of Girls Inc. of San Antonio, and as a board member of KLRN, San Antonio’s public television station. Schroeder is a certified public accountant and Chartered Global Management Accountant with a B.B.A. in accounting from the University of Texas at San Antonio.
“We are adding two highly-talented and successful professionals that broaden the skill set of our board and will enhance our ability to execute on our strategic objective of growing our business," NanoVibronix CEO Brian Murphy said, "We expect Rori and Lulu will be instrumental in advancing strategic initiatives and providing thought leadership in a variety of legal, financial and managerial roles. We have no doubt this experience will be enormously beneficial as we further commercialize our products and expand our manufacturing capabilities to penetrate the healthcare market.”
Headquartered in Elmsford, N.Y., with research and development in Nesher, Israel, NanoVibronix develops medical devices that feature its patented low intensity surface acoustic wave (SAW) technology. The proprietary technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The devices can be administered at home without the assistance of medical professionals. The company’s primary products include PainShield and UroShield, which are portable devices suitable for administration at home without assistance of medical professionals.
The company recently appointed Aurora (Rori) Cassirer and Maria (Lulu) Schroeder to serve as independent directors. Cassirer will serve on the compensation and nominating and governance committees and Schroeder will serve on the Audit Committee. The board is now comprised of eight directors, six of whom are considered ‘independent’ as defined under Nasdaq Listing Rules.
Cassirer is a highly experienced attorney, who has served as a partner in prominent law firms for more than 30 years including Troutman Pepper, where she served on the Executive and Compensation committees, and Jenkins & Gilchrist. In addition to her management responsibilities, Rori has a practice focusing on business litigation and corporate governance issues. She has developed a particular niche in dealing with publicly and privately held biotech/healthtech and biopharma companies. Cassirer has been listed as AV Preeminent by Martindale-Hubbell consistently for the last 20 years as well as being listed in Law & Politics’ New York Super Lawyers for excellence in Business Litigation every year since 2008. Previously, she chaired the Advisory Board of ReferWell, formerly known as Urgent Consult LLC, a health technology startup. She also serves on the Board of Directors of Kids in Need of Defense (KIND), a not-for-profit organization where she served on its Compensation Committee. She is also a member of the Board of Friends of Jerusalem College of Technology and serves on its Development Committee. Cassirer serves as co-chair of the New York State Bar Association International Corporate Compliance Committee and on the Advisory Board of LiveCare Corp., a company that manufactures and distributes remote patient monitoring devices. Cassirer earned her J.D. from New York University.
Schroeder has been a key financial executive at various public and privately-held companies including CST Brands, KCI and Brain Sentinel, where she recently served as chief financial officer. Prior to Brain Sentinel, Schroeder served as vice president, Global Tax of CST Brands, a Fortune 250 retail Oil and Gas company. Prior to that, she served as vice president and treasurer, and head of Tax at Kinetic Concepts Inc. (KCI), a $1.5 billion medtech company that was recently purchased by 3M for $6.7 billion. At KCI, she held key roles in a number of strategic transactions, including two leveraged buyouts and an initial public offering. Schroeder began her career at Ernst & Whinney before joining Deloitte Haskins & Sells. Schroeder is an alumnus of San Antonio Leadership, a premier leadership program of the San Antonio Chamber of Commerce and has served on the Audit Committee for The University of Texas at San Antonio, as treasurer of Girls Inc. of San Antonio, and as a board member of KLRN, San Antonio’s public television station. Schroeder is a certified public accountant and Chartered Global Management Accountant with a B.B.A. in accounting from the University of Texas at San Antonio.
“We are adding two highly-talented and successful professionals that broaden the skill set of our board and will enhance our ability to execute on our strategic objective of growing our business," NanoVibronix CEO Brian Murphy said, "We expect Rori and Lulu will be instrumental in advancing strategic initiatives and providing thought leadership in a variety of legal, financial and managerial roles. We have no doubt this experience will be enormously beneficial as we further commercialize our products and expand our manufacturing capabilities to penetrate the healthcare market.”
Headquartered in Elmsford, N.Y., with research and development in Nesher, Israel, NanoVibronix develops medical devices that feature its patented low intensity surface acoustic wave (SAW) technology. The proprietary technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The devices can be administered at home without the assistance of medical professionals. The company’s primary products include PainShield and UroShield, which are portable devices suitable for administration at home without assistance of medical professionals.